Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
Oecologia
|
March 18, 2017
The decline of the Serengeti Thomson's gazelle population
M Borner, C D FitzGibbon, Mo Borner, et al.
Anticancer Research
|
July 11, 2006
Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples
Farzaneh Pirnia, Steffen Frese, Beat Gloor, et al.
British Journal of Cancer
|
December 25, 2013
Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
I Zlobec, M Hädrich, H Dawson, et al.
British Journal of Cancer
|
May 18, 2001
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
S Vonlanthen, J Heighway, H J Altermatt, et al.
Neuroscience Letters
|
April 25, 1994
Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia
Y Sei, K J Von Lubitz, A S Basile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1990
Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK)
M Borner, U Laffer, C Ludwig, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial
A Ravaud, M Borner, J H Schellens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2002
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration
Ch Dittrich, G Greim, M Borner, et al.
Oncology
|
January 11, 2001
Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer
D P Rauch, C A Maurer, S Aebi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 12, 2001
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours
M Gugger, A Kappeler, S Vonlanthen, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
Oecologia
|
March 18, 2017
The decline of the Serengeti Thomson's gazelle population
M Borner, C D FitzGibbon, Mo Borner, et al.
Anticancer Research
|
July 11, 2006
Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples
Farzaneh Pirnia, Steffen Frese, Beat Gloor, et al.
British Journal of Cancer
|
December 25, 2013
Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
I Zlobec, M Hädrich, H Dawson, et al.
British Journal of Cancer
|
May 18, 2001
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
S Vonlanthen, J Heighway, H J Altermatt, et al.
Neuroscience Letters
|
April 25, 1994
Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia
Y Sei, K J Von Lubitz, A S Basile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1990
Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK)
M Borner, U Laffer, C Ludwig, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial
A Ravaud, M Borner, J H Schellens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2002
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration
Ch Dittrich, G Greim, M Borner, et al.
Oncology
|
January 11, 2001
Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer
D P Rauch, C A Maurer, S Aebi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 12, 2001
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours
M Gugger, A Kappeler, S Vonlanthen, et al.
Page
of 8